Skip to main content

Table 1 Characteristics of ESRD cases and controls at study entry.

From: Analgesics use and ESRD in younger age: a case-control study

  

Cases1 N = 907

Controls1 N = 3622

P

  

N

%

N

%

 

Age (years)

< 40

424

46.8

1644

45.4

 
 

40–50

483

53.2

1978

54.6

.46

Gender

Male

585

64.5

2333

64.4

 
 

Female

322

35.5

1289

35.6

.96

Country

Germany

726

80.0

2890

79.8

 
 

Austria

181

20.0

732

20.2

.87

Education (years)

- 10

603

66.5

1998

55.2

 
 

> 10

304

33.5

1624

44.8

< .001

Smoking

Never

340

37.5

1528

42.2

 
 

Current

277

30.5

694

19.2

 
 

Ex-smoker

290

32.0

1400

38.6

< .001

Alcohol

Seldom

757

83.5

1857

51.3

 
 

Often

150

16.5

1765

48.7

. < .001

History of conditions, diseases

      

Diabetes mellitus

No

748

82.5

3572

98.6

 
 

Yes

159

17.5

50

1.4

< .001

Hypertension

No

134

14.8

3253

89.8

 
 

Yes

773

85.2

369

10.2

< .001

Renal diseases

No

25

2.8

3448

95.2

 
 

Yes

882

97.2

174

4.8

< .001

Urinary tract infections

No

802

88.4

3478

96.0

 
 

Yes

105

11.6

144

4.0

< .001

Family history: chronic renal disease

No

697

76.9

3425

94.6

 
 

Yes

210

23.1

197

5.4

< .001

Migraine

No

766

84.5

3250

89.7

 
 

Yes

141

15.5

372

10.3

< .001

Headache

No

656

72.3

2728

75.3

 
 

Yes

251

27.7

894

24.7

.06

Menstruation problems

No

233

25.7

937

25.9

 
 

Yes

89

9.8

352

9.7

 
 

n.a.

585

64.5

2333

64.4

.99

Arthritic complaints

No

828

91.3

3418

94.4

 
 

Yes

79

8.7

204

5.6

< .001

Chronic back pain

No

710

78.3

2866

79.1

 
 

Yes

197

21.7

756

20.9

.58

Psychological/neurological problems

No

829

91.4

3397

93.8

 
 

Yes

78

8.6

225

6.2

.01

History of treatment

      

Anti-rheumatic treatment

No

892

98.4

3600

99.4

 
 

Yes

15

1.6

22

0.6

< .01

Immuno-suppressive therapy

No

866

95.5

3617

99.9

 
 

Yes

41

4.5

5

0.1

< .001

Drug treatment against cancer

No

889

98.0

3605

99.5

 
 

Yes

18

2.0

17

0.5

< .001

Long-term treatment with antibiotics

No

854

94.2

3526

97.4

 
 

Yes

53

5.8

96

2.7

.000

Complaints (subjectively compared with other persons in the same age span)

      

Gastrointestinal problems

No, rare

577

63.6

2550

70.4

 
 

Similar/more

330

36.4

1072

29.6

< .001

Cardiovascular problems

No, rare

610

67.3

3041

84.0

 
 

Similar/more

297

32.7

581

16.0

< .001

Vomiting

No, rare

612

67.5

3187

88.0

 
 

Similar/more

295

32.5

435

12.0

< .001

Depression

No, rare

719

79.3

3172

87.6

 
 

Similar/more

188

20.7

450

12.4

< .001

Anxiety

No, rare

762

84.0

3259

90.0

 
 

Similar/more

145

16.0

363

10.0

< .001

Sleeplessness

No, rare

542

59.8

2821

77.9

 
 

Similar/more

365

40.2

801

22.1

< .001

Fatigue

No, rare

333

36.7

2490

68.8

 
 

Similar/more

574

63.3

1132

31.2

< .001

Irritability

No, rare

505

55.7

2376

65.6

 
 

Similar/more

402

44.3

1246

34.4

< .001

Stress

No, rare

459

50.6

1713

47.3

 
 

Similar/more

448

49.4

1909

52.7

< .001

Eating problems

No, rare

752

82.9

3368

93.0

 
 

Similar/more

155

17.1

254

7.0

< .001

History of exposures at work site

      

Heavy metal

No

750

82.7

3216

88.8

 
 

Yes

157

17.3

406

11.2

< .001

Other metal dust

No

765

84.3

3240

89.5

 
 

Yes

142

15.7

382

10.5

< .001

Special silicates2

No

847

93.4

3431

94.7

 
 

Yes

60

6.6

191

5.3

.11

Other silicates3

No

796

87.8

3375

93.2

 
 

Yes

111

12.2

247

6.8

< .001

Solvents

No

751

82.8

3188

88.0

 
 

Yes

156

17.2

434

12.0

< .001

Welding & soldering fumes

No

797

87.9

3384

93.4

 
 

Yes

110

12.1

238

6.6

< .001

  1. 1 Deviations from the total number of cases and controls are due to missing information
  2. 2 e.g. quartz, silicon dioxide, fibre glass, silicone
  3. 3 e.g. sand, cement, coal, grain dust